Figure 2.
Percentage of patients with testosterone ≤0.5 ng/ml during the first month of treatment in the phase III comparative study CS21. *p < 0.001 versus leuprolide (pairwise comparisons by Fisher’s exact test) [Adapted from Persson et al. 2009].
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.